Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Known as: HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI), HBV NRTI, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BIOCHEMISTRY Correction for “Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA… Expand
  • figure 5
2016
2016
Auf dem Kongress der Gesellscha für Phytotherapie 2016 wurde eine aktuelle nicht-interventionelle Studie zur Behandlung von… Expand
2015
2015
Significance Nucleoside analog reverse transcriptase inhibitors (NRTIs) are the cornerstones of treatment for fighting HIV… Expand
  • figure 5
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
Nucleoside reverse transcriptase inhibitors (NRTIs) remain a critical component of therapy for HIV-infected patients. The drugs… Expand
  • table I
  • table II
2012
2012
In two 48‐week studies in naïve subjects, dolutegravir with NRTI of choice has shown non‐inferiority to raltegravir and, with ABC… Expand
2008
2008
While it is known that selection for specific HIV-1 drug resistance-associated mutations (DRM) occurs following ART failure, the… Expand
  • table 1
  • figure 1
2007
2007
BACKGROUND Intracellular nucleoside reverse transcriptase inhibitor triphosphate (NRTI-TP) concentrations are crucial in… Expand
  • table 1
  • table 2
  • figure 1
2007
2007
We evaluated the efficacy of tenofovir (TDF) – and didanosine (ddI)-containing backbones in HIV-infected experienced subjects. We… Expand
  • table 1
  • table 2
  • table 3